UPC clarifies inventive step standard in Amgen–Sanofi appeal case
Amgen won a dispute over its cholesterol-lowering patent as UPC appeal court judges restored it and clarified the court’s inventive-step test, confirming the “realistic starting point” approach and rejecting Sanofi’s attempt...To view the full article, register now.
Already a subscriber? Click here to view full article